References
1. Levine JM, Whitton JA, Ginsberg JP, Green DM, Leisenring WM, Stovall
M, et al. Nonsurgical premature menopause and reproductive implications
in survivors of childhood cancer: A report from the Childhood Cancer
Survivor Study. Cancer. 2018 01;124(5):1044–52.
2. Chemaitilly W, Li Z, Krasin MJ, Brooke RJ, Wilson CL, Green DM, et
al. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A
Report From the St. Jude Lifetime Cohort. J Clin Endocrinol Metab. 2017
01;102(7):2242–50.
3. Chow EJ, Stratton KL, Leisenring WM, Oeffinger KC, Sklar CA,
Donaldson SS, et al. Pregnancy after chemotherapy in male and female
survivors of childhood cancer treated between 1970 and 1999: a report
from the Childhood Cancer Survivor Study cohort. Lancet Oncol.
2016;17(5):567–76.
4. Bresters D, Emons JAM, Nuri N, Ball LM, Kollen WJW, Hannema SE, et
al. Ovarian insufficiency and pubertal development after hematopoietic
stem cell transplantation in childhood. Pediatr Blood Cancer. 2014
Nov;61(11):2048–53.
5. Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Wiebe T,
et al. High risk of azoospermia in men treated for childhood cancer. Int
J Androl. 2011 Feb;34(1):69–76.
6. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC,
et al. Fertility of male survivors of childhood cancer: a report from
the Childhood Cancer Survivor Study. J Clin Oncol Off J Am Soc Clin
Oncol. 2010 Jan 10;28(2):332–9.
7. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, et al.
Premature menopause in survivors of childhood cancer: a report from the
childhood cancer survivor study. J Natl Cancer Inst. 2006 Jul
5;98(13):890–6.
8. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, et
al. Acute ovarian failure in the childhood cancer survivor study. J Clin
Endocrinol Metab. 2006 May;91(5):1723–8.
9. Wasilewski-Masker K, Seidel KD, Leisenring W, Mertens AC,
Shnorhavorian M, Ritenour CW, et al. Male infertility in long-term
survivors of pediatric cancer: a report from the childhood cancer
survivor study. J Cancer Surviv Res Pract. 2014 Sep;8(3):437–47.
10. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M,
Weathers RE, et al. Infertility, infertility treatment, and achievement
of pregnancy in female survivors of childhood cancer: a report from the
Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013
Aug;14(9):873–81.
11. Children’s Oncology Group Long-Term Follow-Up Guidelines for
Survivors of Pediatric, Adolescent, and Young Adult Cancers.
[Internet]. 2018 Oct [cited 2019 Apr 11]. Available from:
www.survivorshipguidelines.org
12. Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, et
al. Recommendations for gonadotoxicity surveillance in male childhood,
adolescent, and young adult cancer survivors: a report from the
International Late Effects of Childhood Cancer Guideline Harmonization
Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol.
2017;18(2):e75–90.
13. van Dorp W, Mulder RL, Kremer LCM, Hudson MM, van den Heuvel-Eibrink
MM, van den Berg MH, et al. Recommendations for Premature Ovarian
Insufficiency Surveillance for Female Survivors of Childhood,
Adolescent, and Young Adult Cancer: A Report From the International Late
Effects of Childhood Cancer Guideline Harmonization Group in
Collaboration With the PanCareSurFup Consortium. J Clin Oncol Off J Am
Soc Clin Oncol. 2016 01;34(28):3440–50.
14. Kim J, Mersereau JE. A pilot study about female adolescent/young
childhood cancer survivors’ knowledge about reproductive health and
their views about consultation with a fertility specialist. Palliat
Support Care. 2015 Oct;13(5):1251–60.
15. Lehmann V, Keim MC, Nahata L, Shultz EL, Klosky JL, Tuinman MA, et
al. Fertility-related knowledge and reproductive goals in childhood
cancer survivors: short communication. Hum Reprod Oxf Engl. 2017
01;32(11):2250–3.
16. Oosterhuis BE, Goodwin T, Kiernan M, Hudson MM, Dahl GV. Concerns
about infertility risks among pediatric oncology patients and their
parents. Pediatr Blood Cancer. 2008 Jan;50(1):85–9.
17. Gilleland Marchak J, Seidel KD, Mertens AC, Ritenour CWM,
Wasilewski-Masker K, Leisenring WM, et al. Perceptions of risk of
infertility among male survivors of childhood cancer: A report from the
Childhood Cancer Survivor Study. Cancer. 2018 01;124(11):2447–55.
18. Ethics Committee of the American Society for Reproductive Medicine.
Electronic address: ASRM@asrm.org. Fertility preservation and
reproduction in patients facing gonadotoxic therapies: an Ethics
Committee opinion. Fertil Steril. 2018;110(3):380–6.
19. Oktay K, Harvey BE, Loren AW. Fertility Preservation in Patients
With Cancer: ASCO Clinical Practice Guideline Update Summary. J Oncol
Pract. 2018;14(6):381–5.
20. Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R,
et al. Adolescent and Young Adult Oncology, Version 2.2018, NCCN
Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw
JNCCN. 2018 Jan;16(1):66–97.
21. Köhler TS, Kondapalli LA, Shah A, Chan S, Woodruff TK, Brannigan RE.
Results from the survey for preservation of adolescent reproduction
(SPARE) study: gender disparity in delivery of fertility preservation
message to adolescents with cancer. J Assist Reprod Genet. 2011
Mar;28(3):269–77.
22. Nahata L, Caltabellotta NM, Yeager ND, Lehmann V, Whiteside SL,
O’Brien SH, et al. Fertility perspectives and priorities among male
adolescents and young adults in cancer survivorship. Pediatr Blood
Cancer. 2018;65(7):e27019.
23. Fuchs A, Kashanian JA, Clayman ML, Gosiengfiao Y, Lockart B,
Woodruff TK, et al. Pediatric Oncology Providers’ Attitudes and Practice
Patterns Regarding Fertility Preservation in Adolescent Male Cancer
Patients. J Pediatr Hematol Oncol. 2016 Mar;38(2):118–22.
24. Rodriguez-Wallberg KA, Marklund A, Lundberg F, Wikander I,
Milenkovic M, Anastacio A, et al. A prospective study of women and girls
undergoing fertility preservation due to oncologic and non-oncologic
indications in Sweden-Trends in patients’ choices and benefit of the
chosen methods after long-term follow up. Acta Obstet Gynecol Scand.
2019 May;98(5):604–15.
25. Quinn GP, Block RG, Clayman ML, Kelvin J, Arvey SR, Lee J-H, et al.
If you did not document it, it did not happen: rates of documentation of
discussion of infertility risk in adolescent and young adult oncology
patients’ medical records. J Oncol Pract. 2015 Mar;11(2):137–44.
26. Skaczkowski G, White V, Thompson K, Bibby H, Coory M, Pinkerton R,
et al. Factors influencing the documentation of fertility-related
discussions for adolescents and young adults with cancer. Eur J Oncol
Nurs Off J Eur Oncol Nurs Soc. 2018 Jun;34:42–8.
27. Hohmann C, Borgmann-Staudt A, Rendtorff R, Reinmuth S, Holzhausen S,
Willich SN, et al. Patient counselling on the risk of infertility and
its impact on childhood cancer survivors: results from a national
survey. J Psychosoc Oncol. 2011;29(3):274–85.
28. Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB,
et al. Discussion of fertility preservation with newly diagnosed
patients: oncologists’ views. J Cancer Surviv Res Pract. 2007
Jun;1(2):146–55.
29. Children’s Oncology Group Long-Term Follow-Up Guidelines for
Survivors of Pediatric, Adolescent, and Young Adult Cancers.
[Internet]. 2018 Oct [cited 2019 Apr 11]. Available from:
www.survivorshipguidelines.org
30. Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, et
al. Recommendations for gonadotoxicity surveillance in male childhood,
adolescent, and young adult cancer survivors: a report from the
International Late Effects of Childhood Cancer Guideline Harmonization
Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol.
2017;18(2):e75–90.
31. van Dorp W, Mulder RL, Kremer LCM, Hudson MM, van den Heuvel-Eibrink
MM, van den Berg MH, et al. Recommendations for Premature Ovarian
Insufficiency Surveillance for Female Survivors of Childhood,
Adolescent, and Young Adult Cancer: A Report From the International Late
Effects of Childhood Cancer Guideline Harmonization Group in
Collaboration With the PanCareSurFup Consortium. J Clin Oncol Off J Am
Soc Clin Oncol. 2016 01;34(28):3440–50.
32. Suh E, Daugherty CK, Wroblewski K, Lee H, Kigin ML, Rasinski KA, et
al. General internists’ preferences and knowledge about the care of
adult survivors of childhood cancer: a cross-sectional survey. Ann
Intern Med. 2014 Jan 7;160(1):11–7.
33. Armuand GM, Rodriguez-Wallberg KA, Wettergren L, Ahlgren J, Enblad
G, Höglund M, et al. Sex differences in fertility-related information
received by young adult cancer survivors. J Clin Oncol Off J Am Soc Clin
Oncol. 2012 Jun 10;30(17):2147–53.
34. Panagiotopoulou N, van Delft FW, Stewart JA. Fertility preservation
knowledge, attitudes and intentions among children by proxy and
adolescents with cancer. Reprod Biomed Online. 2019 Nov;39(5):802–8.
35. Iliodromiti S, Anderson RA, Nelson SM. Technical and performance
characteristics of anti-Müllerian hormone and antral follicle count as
biomarkers of ovarian response. Hum Reprod Update. 2015
Dec;21(6):698–710.
36. Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman
S, et al. Antimüllerian hormone as a predictor of natural fecundability
in women aged 30-42 years. Obstet Gynecol. 2011 Apr;117(4):798–804.
37. Hagen CP, Aksglaede L, Sørensen K, Mouritsen A, Andersson A-M,
Petersen JH, et al. Individual serum levels of anti-Müllerian hormone in
healthy girls persist through childhood and adolescence: a longitudinal
cohort study. Hum Reprod Oxf Engl. 2012 Mar;27(3):861–6.
38. Finkelstein JS, Lee H, Karlamangla A, Neer RM, Sluss PM,
Burnett-Bowie S-AM, et al. Antimullerian Hormone and Impending Menopause
in Late Reproductive Age: The Study of Women’s Health Across the Nation.
J Clin Endocrinol Metab. 2020 Apr 1;105(4).
39. Depmann M, Eijkemans MJC, Broer SL, Tehrani FR, Solaymani-Dodaran M,
Azizi F, et al. Does AMH relate to timing of menopause? Results of an
Individual Patient Data meta- analysis. J Clin Endocrinol Metab. 2018
Jul 18;
40. Su HI, Kwan B, Whitcomb BW, Shliakhsitsava K, Dietz AC, Stark SS, et
al. Modeling variation in the reproductive lifespan of female adolescent
and young adult cancer survivors using AMH. J Clin Endocrinol Metab.
2020 Apr 9;
41. Bentzen JG, Forman JL, Pinborg A, Lidegaard Ø, Larsen EC,
Friis-Hansen L, et al. Ovarian reserve parameters: a comparison between
users and non-users of hormonal contraception. Reprod Biomed Online.
2012 Dec;25(6):612–9.
42. Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring
WM, et al. The cyclophosphamide equivalent dose as an approach for
quantifying alkylating agent exposure: a report from the Childhood
Cancer Survivor Study. Pediatr Blood Cancer. 2014 Jan;61(1):53–67.
43. Chung K, Donnez J, Ginsburg E, Meirow D. Emergency IVF versus
ovarian tissue cryopreservation: decision making in fertility
preservation for female cancer patients. Fertil Steril. 2013
May;99(6):1534–42.
44. Meirow D, Schiff E. Appraisal of chemotherapy effects on
reproductive outcome according to animal studies and clinical data. J
Natl Cancer Inst Monogr. 2005;(34):21–5.
45. Anderson RA, Wallace WHB, Telfer EE. Ovarian tissue cryopreservation
for fertility preservation: clinical and research perspectives. Hum
Reprod Open. 2017;2017(1):hox001.
46. Donnez J, Dolmans M-M. Fertility Preservation in Women. N Engl J
Med. 2018 25;378(4):400–1.
47. Ethics Committee of the American Society for Reproductive Medicine.
Electronic address: ASRM@asrm.org. Fertility preservation and
reproduction in patients facing gonadotoxic therapies: an Ethics
Committee opinion. Fertil Steril. 2018;110(3):380–6.
48. Jensen AK, Macklon KT, Fedder J, Ernst E, Humaidan P, Andersen CY.
86 successful births and 9 ongoing pregnancies worldwide in women
transplanted with frozen-thawed ovarian tissue: focus on birth and
perinatal outcome in 40 of these children. J Assist Reprod Genet. 2017
Mar;34(3):325–36.
49. Jadoul P, Guilmain A, Squifflet J, Luyckx M, Votino R, Wyns C, et
al. Efficacy of ovarian tissue cryopreservation for fertility
preservation: lessons learned from 545 cases. Hum Reprod Oxf Engl. 2017
01;32(5):1046–54.
50. Christianson MS, Lindheim SR. Pediatric ovarian tissue
cryopreservation: time to lift the experimental label? Fertil Steril.
2018;109(5):805–6.
51. Meirow D, Ra’anani H, Shapira M, Brenghausen M, Derech Chaim S,
Aviel-Ronen S, et al. Transplantations of frozen-thawed ovarian tissue
demonstrate high reproductive performance and the need to revise
restrictive criteria. Fertil Steril. 2016;106(2):467–74.
52. McLaughlin M, Kelsey TW, Wallace WHB, Anderson RA, Telfer EE.
Non-growing follicle density is increased following adriamycin,
bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult
human ovary. Hum Reprod Oxf Engl. 2017;32(1):165–74.
53. Gellert SE, Pors SE, Kristensen SG, Bay-Bjørn AM, Ernst E, Yding
Andersen C. Transplantation of frozen-thawed ovarian tissue: an update
on worldwide activity published in peer-reviewed papers and on the
Danish cohort. J Assist Reprod Genet. 2018 Apr;35(4):561–70.
54. Poirot C, Fortin A, Lacorte JM, Akakpo JP, Genestie C, Vernant JP,
et al. Impact of cancer chemotherapy before ovarian cortex
cryopreservation on ovarian tissue transplantation. Hum Reprod Oxf Engl.
2019 Jun 4;34(6):1083–94.
55. Dolmans M-M, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of
transferring malignant cells with transplanted frozen-thawed ovarian
tissue. Fertil Steril. 2013 May;99(6):1514–22.
56. Luyckx V, Dolmans M-M, Vanacker J, Legat C, Fortuño Moya C, Donnez
J, et al. A new step toward the artificial ovary: survival and
proliferation of isolated murine follicles after autologous
transplantation in a fibrin scaffold. Fertil Steril. 2014
Apr;101(4):1149–56.
57. Andersen CY, Bollerup AC, Kristensen SG. Defining quality assurance
and quality control measures in connection with ovarian tissue
cryopreservation and transplantation: a call to action. Hum Reprod Oxf
Engl. 2018 01;33(7):1201–4.
58. Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et
al. Recommendations for cardiomyopathy surveillance for survivors of
childhood cancer: a report from the International Late Effects of
Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015
Mar;16(3):e123-136.
59. Critchley HO. Factors of importance for implantation and problems
after treatment for childhood cancer. Med Pediatr Oncol. 1999
Jul;33(1):9–14.
60. Green DM, Sklar CA, Boice JD, Mulvihill JJ, Whitton JA, Stovall M,
et al. Ovarian failure and reproductive outcomes after childhood cancer
treatment: results from the Childhood Cancer Survivor Study. J Clin
Oncol Off J Am Soc Clin Oncol. 2009 May 10;27(14):2374–81.
61. Lie Fong S, van den Heuvel-Eibrink MM, Eijkemans MJC, Schipper I,
Hukkelhoven CWPM, Laven JSE. Pregnancy outcome in female childhood
cancer survivors. Hum Reprod Oxf Engl. 2010 May;25(5):1206–12.
62. Hartnett KP, Ward KC, Kramer MR, Lash TL, Mertens AC, Spencer JB, et
al. The risk of preterm birth and growth restriction in pregnancy after
cancer. Int J Cancer. 2017 01;141(11):2187–96.
63. Flyckt R, Kotlyar A, Arian S, Eghtesad B, Falcone T, Tzakis A.
Deceased donor uterine transplantation. Fertil Steril. 2017
Mar;107(3):e13.
64. van der Kooi A-LLF, Kelsey TW, van den Heuvel-Eibrink MM, Laven JSE,
Wallace WHB, Anderson RA. Perinatal complications in female survivors of
cancer: a systematic review and meta-analysis. Eur J Cancer Oxf Engl
1990. 2019;111:126–37.
65. WHO laboratory manual for the examination and processing of human
semen. 5th ed. Geneva: World Health Organization; 2010. 271 p.
66. Pereira ML, Garcia e Costa F. The blood-testis barrier as a target
of some chemotherapeutic agents. Chemotherapy. 2007;53(6):446–8.
67. Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA, et al.
Cumulative alkylating agent exposure and semen parameters in adult
survivors of childhood cancer: a report from the St Jude Lifetime Cohort
Study. Lancet Oncol. 2014 Oct;15(11):1215–23.
68. Shalet SM. Effect of irradiation treatment on gonadal function in
men treated for germ cell cancer. Eur Urol. 1993;23(1):148–51;
discussion 152.
69. Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, Jaman N, et al.
Semen quality before and after gonadotoxic treatment. Hum Reprod Oxf
Engl. 2005 Mar;20(3):774–81.
70. Green DM, Zhu L, Zhang N, Sklar CA, Ke RW, Kutteh WH, et al. Lack of
specificity of plasma concentrations of inhibin B and
follicle-stimulating hormone for identification of azoospermic survivors
of childhood cancer: a report from the St Jude lifetime cohort study. J
Clin Oncol Off J Am Soc Clin Oncol. 2013 Apr 1;31(10):1324–8.
71. Kelsey TW, McConville L, Edgar AB, Ungurianu AI, Mitchell RT,
Anderson RA, et al. Follicle Stimulating Hormone is an accurate
predictor of azoospermia in childhood cancer survivors. PloS One.
2017;12(7):e0181377.
72. van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH,
Hakvoort-Cammel FG, van den Bos C, et al. Inhibin B is superior to FSH
as a serum marker for spermatogenesis in men treated for Hodgkin’s
lymphoma with chemotherapy during childhood. Hum Reprod Oxf Engl. 2007
Dec;22(12):3215–22.
73. van Casteren NJ, van der Linden GHM, Hakvoort-Cammel FGAJ, Hählen K,
Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer
treatment on fertility markers in adult male long-term survivors.
Pediatr Blood Cancer. 2009 Jan;52(1):108–12.
74. Mabeck LM, Jensen MS, Toft G, Thulstrup M, Andersson M, Jensen TK,
et al. Fecundability according to male serum inhibin B–a prospective
study among first pregnancy planners. Hum Reprod Oxf Engl. 2005
Oct;20(10):2909–15.
75. Howell SJ, Shalet SM. Testicular function following chemotherapy.
Hum Reprod Update. 2001 Aug;7(4):363–9.
76. De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset
R, et al. Increased aneuploidy in spermatozoa from testicular tumour
patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum
Reprod Oxf Engl. 2001 Jun;16(6):1204–8.
77. Ståhl O, Eberhard J, Cavallin-Ståhl E, Jepson K, Friberg B,
Tingsmark C, et al. Sperm DNA integrity in cancer patients: the effect
of disease and treatment. Int J Androl. 2009 Dec;32(6):695–703.
78. Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M. Causes
of hypogonadotropic hypogonadism predict response to gonadotropin
substitution in adults. Andrology. 2016 Jan;4(1):87–94.
79. Schlegel PN. Testicular sperm extraction: microdissection improves
sperm yield with minimal tissue excision. Hum Reprod Oxf Engl. 1999
Jan;14(1):131–5.
80. Bernie AM, Mata DA, Ramasamy R, Schlegel PN. Comparison of
microdissection testicular sperm extraction, conventional testicular
sperm extraction, and testicular sperm aspiration for nonobstructive
azoospermia: a systematic review and meta-analysis. Fertil Steril. 2015
Nov;104(5):1099-1103.e1-3.
81. Shin T, Kobayashi T, Shimomura Y, Iwahata T, Suzuki K, Tanaka T, et
al. Microdissection testicular sperm extraction in Japanese patients
with persistent azoospermia after chemotherapy. Int J Clin Oncol. 2016
Dec;21(6):1167–71.
82. Hsiao W, Stahl PJ, Osterberg EC, Nejat E, Palermo GD, Rosenwaks Z,
et al. Successful treatment of postchemotherapy azoospermia with
microsurgical testicular sperm extraction: the Weill Cornell experience.
J Clin Oncol Off J Am Soc Clin Oncol. 2011 Apr 20;29(12):1607–11.
83. Morgan S, Davies S, Palmer S, Plaster M. Sex, drugs, and rock “n”
roll: caring for adolescents and young adults with cancer. J Clin Oncol
Off J Am Soc Clin Oncol. 2010 Nov 10;28(32):4825–30.
84. Rodriguez-Wallberg KA, Borgström B, Petersen C, Thurin-Kjellberg A,
Mörse H, Giwercman A, et al. National guidelines and multilingual
age-adapted patient brochures and videos as decision aids for fertility
preservation (FP) of children and teenagers with cancer-A
multidisciplinary effort to improve children’s information and access to
FP in Sweden. Acta Obstet Gynecol Scand. 2019 May;98(5):679–80.